论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
基于社交媒体平台的中国成年斑秃患者对 JAK 抑制剂治疗的看法:一项定性分析
Authors Song H , Xiao Y, Wang D
Received 24 December 2024
Accepted for publication 10 May 2025
Published 3 June 2025 Volume 2025:19 Pages 1653—1660
DOI http://doi.org/10.2147/PPA.S510171
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jongwha Chang
Haizhen Song, Yuanyuan Xiao, Dong Wang
Department of Dermatology, Deyang People’s Hospital, Deyang, Sichuan, People’s Republic of China
Correspondence: Haizhen Song, Deyang City People’s Hospital, Taishan, North Road, Jingyang District, Deyang, Sichuan, 610041, People’s Republic of China, Tel +86-28-19981667064, Email 451839051@qq.com
Background: Alopecia areata (AA) is a common autoimmune disorder causing non-scarring hair loss. Janus kinase (JAK) inhibitors have emerged as a promising new treatment approach for AA. This study aimed to investigate the perspectives of Chinese adult AA patients on JAK inhibitor therapy through a qualitative analysis of social media discussions.
Methods: Keyword searches were conducted on two major Chinese social media platforms, Bidu and Sina Weibo, to retrieve AA-related discussion posts within China. A total of 300 posts met the inclusion criteria and were analyzed using natural language processing techniques. All data used in this study were publicly available, anonymized, and obtained without interaction with human subjects, ensuring compliance with ethical standards. High-frequency terms were categorized into four main themes: drug information, efficacy and side effects, shared experiences, and treatment choices.
Results: Tofacitinib and baricitinib were the most frequently mentioned JAK inhibitors. Patients’ discussions focused on treatment efficacy, relapse after discontinuation, and side effects. Specific attention was given to treatment effects at different time points. The psychological burden and emotional impact of AA emerged as significant themes in patients’ shared experiences. Patients’ discussions on treatment choices and brand selection reflected their active involvement in decision-making and desire for personalized treatment options.
Conclusion: This study reveals the significant interest and hope that Chinese adult AA patients have in JAK inhibitor therapy. The findings underscore the importance of comprehensive patient education, individualized risk assessment, and shared decision-making in the management of AA. Understanding patients’ perspectives is crucial for developing patient-centered care strategies and improving treatment outcomes. Previous studies have demonstrated the feasibility and value of using social media data to explore patient perceptions and health behaviors in various diseases.
Keywords: alopecia areata, janus kinase inhibitors, qualitative analysis, patient needs